Cell Source, Inc. (CLCS) Net income 2015–2024
Cell Source, Inc. (CLCS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$4.5MFY2024 · since FY2015: -$2.5M → -$4.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$4.5M | +15.2% |
| FY2023 | -$5.3M | -3.0% |
| FY2022 | -$5.2M | +5.6% |
| FY2021 | -$5.5M | -20.0% |
| FY2020 | -$4.6M | -1.9% |
| FY2019 | -$4.5M | -111.4% |
| FY2018 | -$2.1M | +31.3% |
| FY2017 | -$3.1M | -218.5% |
| FY2016 | -$967,782 | +61.4% |
| FY2015 | -$2.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLCS financial trends
CLCS RevenueCLCS Net marginCLCS Gross profitCLCS Gross marginCLCS Operating incomeCLCS Operating marginCLCS Operating cash flowCLCS Free cash flowCLCS Capital expendituresCLCS Return on equityCLCS Stock buybacksCLCS Dividends paidCLCS Total assetsCLCS Total liabilitiesCLCS Shareholders’ equityCLCS overview →